These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22233234)

  • 1. Focal therapy for renal mass lesions: where do we stand in 2012?
    Rane A; Stein R; Cadeddu J
    BJU Int; 2012 Feb; 109(4):491-2. PubMed ID: 22233234
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: 'nephron-sparing surgery for renal cancers'.
    Klatte T
    Curr Opin Urol; 2014 Sep; 24(5):435-6. PubMed ID: 25004392
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple nephron-sparing procedures in solitary kidney with recurrent, metachronous, nonfamilial renal cell carcinoma.
    Nosnik IP; Mouraviev V; Nelson R; Polascik TJ
    Urology; 2006 Dec; 68(6):1343.e1-3. PubMed ID: 17141824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal ablative therapy: radiofrequency ablation and cryoablation.
    Raman JD; Hall DW; Cadeddu JA
    J Surg Oncol; 2009 Dec; 100(8):639-44. PubMed ID: 20017159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephron-sparing probe ablative therapy: long-term outcomes.
    Matin SF; Ahrar K
    Curr Opin Urol; 2008 Mar; 18(2):150-6. PubMed ID: 18303535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive surgery using ablative modalities for the localized renal mass.
    Kimura M; Baba S; Polascik TJ
    Int J Urol; 2010 Mar; 17(3):215-27. PubMed ID: 20070411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy ablative techniques for treatment of small renal tumors.
    Wen CC; Nakada SY
    Curr Opin Urol; 2006 Sep; 16(5):321-6. PubMed ID: 16905975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors: C. J. Weight, J. H. Kaouk, N. J. Hegarty, E. M. Remer, C. M. O'Malley, B. R. Lane, I. S. Gill and A. C. Novick, J Urol 2008; 179: 1277-1283.
    Gemery JM; Hoffer EK
    J Urol; 2009 Feb; 181(2):918-9. PubMed ID: 19095264
    [No Abstract]   [Full Text] [Related]  

  • 9. Ablative techniques for the management of kidney cancer.
    Hafron J; Kaouk JH
    Nat Clin Pract Urol; 2007 May; 4(5):261-9. PubMed ID: 17483811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of ablative techniques for small renal masses.
    Clements T; Lin YK; Raman JD
    Expert Rev Anticancer Ther; 2011 Jun; 11(6):879-91. PubMed ID: 21707285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Minimally invasive vs. open surgical procedures in the treatment of renal cell carcinoma].
    Thüroff JW; Roos F
    Urologe A; 2015 Feb; 54(2):231-3. PubMed ID: 25656044
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of cryoablation, radiofrequency ablation and high-intensity focused ultrasound for treating small renal tumours.
    Weld KJ; Landman J
    BJU Int; 2005 Dec; 96(9):1224-9. PubMed ID: 16287435
    [No Abstract]   [Full Text] [Related]  

  • 13. The future of nephron sparing procedures for renal masses: balancing costs, efficacy, patient outcomes and experience.
    Lotan Y
    J Urol; 2011 May; 185(5):1560-1. PubMed ID: 21419436
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness analysis of nephron sparing options for the management of small renal masses.
    Chang SL; Cipriano LE; Harshman LC; Garber AM; Chung BI
    J Urol; 2011 May; 185(5):1591-7. PubMed ID: 21419445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preexisting chronic kidney disease and renal tumor ablation: preliminary answers and persistent questions.
    Gervais DA
    J Vasc Interv Radiol; 2012 Jan; 23(1):46-7. PubMed ID: 22221472
    [No Abstract]   [Full Text] [Related]  

  • 16. Thermal ablation of renal cell carcinoma: triage, treatment, and follow-up.
    Thumar AB; Trabulsi EJ; Lallas CD; Brown DB
    J Vasc Interv Radiol; 2010 Aug; 21(8 Suppl):S233-41. PubMed ID: 20656233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy.
    Nguyen CT; Lane BR; Kaouk JH; Hegarty N; Gill IS; Novick AC; Campbell SC
    J Urol; 2008 Jul; 180(1):104-9; discussion 109. PubMed ID: 18485401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining failure after renal ablative therapy for renal cell carcinoma: false-negative and false-positive imaging findings.
    Matin SF
    Urology; 2010 Jun; 75(6):1254-7. PubMed ID: 20299082
    [No Abstract]   [Full Text] [Related]  

  • 19. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study.
    Matin SF; Ahrar K; Cadeddu JA; Gervais DA; McGovern FJ; Zagoria RJ; Uzzo RG; Haaga J; Resnick MI; Kaouk J; Gill IS
    J Urol; 2006 Nov; 176(5):1973-7. PubMed ID: 17070224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal surgery--is technique more important than tumor or patient characteristics in preserving kidney function?
    Goldfarb DA
    J Urol; 2011 Feb; 185(2):383-4. PubMed ID: 21168169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.